Jeffrey Chambers, MD
Cardiovascular Disease · Minneapolis, MNNPI 1437192598
Payments from drug & device makers
Across 695 payments — averaging $5230.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$2.1M
- Vascular Solutions, Inc.$842K
- Medtronic$139K
- Penumbra, Inc.$126K
- Cardiovascular Systems Inc.$119K
- Boston Scientific$108K
- plus $184K from 27 others
Across 10 payments — averaging $1767.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arrow International, Inc.$10K
- Philips North America LLC$7K
- ZOLL Circulation Inc$373
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 28 | $2,118,363 |
| Vascular Solutions, Inc. | 13 | $841,634 |
| Medtronic(2 entities) | 72 | $138,931 |
| Penumbra, Inc. | 19 | $126,176 |
| Cardiovascular Systems Inc. | 83 | $119,009 |
| Boston Scientific | 175 | $107,822 |
| Abbott | 79 | $54,828 |
| Inari Medical, Inc. | 41 | $37,903 |
| Cardio Flow, Inc. | 1 | $25,000 |
| ZOLL Circulation Inc | 22 | $21,086 |
| Philips North America LLC | 6 | $19,816 |
| Opsens Inc. | 37 | $4,901 |
| Novartis | 1 | $4,450 |
| E.r. Squibb & Sons, L.L.C. | 2 | $2,827 |
| Cordis US CORP. | 1 | $2,400 |
| Arrow International, Inc. | 7 | $2,291 |
| Edwards Lifesciences | 32 | $1,980 |
| Merit Medical Systems Inc | 3 | $1,753 |
| Ancora Heart, Inc. | 6 | $860 |
| Heartflow, Inc. | 10 | $819 |
| Abiomed | 20 | $809 |
| Cvrx, Inc. | 9 | $453 |
| Biotronik Inc. | 4 | $337 |
| Siemens Medical Solutions USA, Inc. | 6 | $298 |
| Cardiva Medical, Inc. | 8 | $274 |
| Recor Medical Inc | 1 | $187 |
| Shockwave Medical, Inc | 1 | $122 |
| Scpharmaceuticals Inc. | 1 | $75 |
| Stryker | 3 | $54 |
| GE HealthCare | 1 | $24 |
| Terumo Medical Corporation | 1 | $16 |
| Livanova USA, Inc. | 1 | $13 |
| Chiesi USA, Inc. | 1 | $12 |
How this compares
$3,635,521 in reported general payments places this provider in the 95th percentile of 451 cardiovascular disease providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Minneapolis
- Thomas KnickelbineMinneapolis$1.6M
- Tamas AlexyMinneapolis$1.5M
- Joao CavalcanteMinneapolis$1.4M
- Daniel DuprezMinneapolis$1.2M
- Markus MeyerMinneapolis$1.1M
- Thenappan ThenappanMinneapolis$809K
- Mario GoesslMinneapolis$770K
- David Miranda HerreraMinneapolis$760K
- Yader Sandoval PichardoMinneapolis$701K
- Daniel DulasMinneapolis$632K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.